Genetic differences in metabolism of benzo(a)pyrene in cultured epidermal and dermal cells of responsive and nonresponsive mice.

Abstract:

:Genetic differences in metabolism of benzo(a)pyrene (BP) were investigated using cultured epidermal keratinocytes and dermal fibroblasts isolated from four inbred strains of mice: C3H/HeJms and C57BL/6J that are responsive; and DBA/2 and AKR/Jms that are nonresponsive in terms of inducibility of aryl hydrocarbon hydroxylase (AHH) activity. Primary cultures of epidermal and dermal cells isolated from newborn mice were treated with benz(a)anthracene for 24 hr. In both types of cells, AHH activity was induced in all four strains of mice, irrespective of their responsiveness in vivo. In the epidermal cells, basal AHH activity varied within a relatively small range of 4.6 to 8.8 pmol per mg protein per hr, and the activity was increased 4.4 to 8.7 times by benz(a)anthracene treatment. There was no difference in the extent of the induction in different strains of mice. In dermal cells, the basal level of AHH activity was in the range of 3.6 to 9.1 pmol per mg protein per hr, and benz(a)anthracene treatment induced AHH, but to various degrees depending on the responsiveness in vivo. Epidermal cells of the responsive mice metabolized more than 90% of the added BP in 48 hr, while those of nonresponsive mice metabolized only 60 to 70%. Dermal cells also metabolized BP, but to a lesser extent than did epidermal cells, and there was no strain difference in its metabolism. Time-course studies revealed that epidermal cells of responsive mice metabolized BP more rapidly than did those of nonresponsive mice. The activities of epidermal and dermal cells to metabolize BP were further demonstrated by a cell-mediated mutation assay. Consistent with the results of time-course analysis of the metabolites, shorter treatments with BP (less than 24 hr) showed a clear difference in BP metabolism associated with responsiveness.

journal_name

Cancer Res

journal_title

Cancer research

authors

Hosomi J,Nemoto N,Kuroki T

subject

Has Abstract

pub_date

1983-08-01 00:00:00

pages

3643-8

issue

8

eissn

0008-5472

issn

1538-7445

journal_volume

43

pub_type

杂志文章
  • Frequent alteration of p63 expression in human primary bladder carcinomas.

    abstract::p63, a recently identified member of the p53 gene family, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. To explore the penetrance of p63 in bladder carcinogenesis, we performed expression and mutation analyses of two major isotypes, TAp63 and deltaNp63, in 63 bladder...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Park BJ,Lee SJ,Kim JI,Lee SJ,Lee CH,Chang SG,Park JH,Chi SG

    更新日期:2000-07-01 00:00:00

  • High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.

    abstract::Human B-cell lymphomas are frequently associated with specific genetic changes caused by chromosomal translocations that activate proto-oncogenes. For lymphomas of mice expressing murine leukemia virus, mutagenic proviral insertions are thought to play a similar role. Here we report studies designed to determine wheth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3885

    authors: Shin MS,Fredrickson TN,Hartley JW,Suzuki T,Akagi K,Morse HC 3rd

    更新日期:2004-07-01 00:00:00

  • Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization.

    abstract::We used comparative genomic hybridization to study malignant fibrous histiocytomas (MFHs) from 19 patients to detect changes in the copy number of DNA sequences, along entire chromosomes. Together with losses and gains in various chromosomal regions, distinct high-level amplifications were found at six loci (4q12-21, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sakabe T,Shinomiya T,Mori T,Ariyama Y,Fukuda Y,Fujiwara T,Nakamura Y,Inazawa J

    更新日期:1999-02-01 00:00:00

  • Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

    abstract::Immunosuppression may contribute to the progression of cancer. In this study we assessed the structural and functional status of T cells from tumor specimens obtained from patients with early stage non-small cell lung cancer and late-stage ovarian cancer. Although some groups have described structural alterations in t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Woo EY,Chu CS,Goletz TJ,Schlienger K,Yeh H,Coukos G,Rubin SC,Kaiser LR,June CH

    更新日期:2001-06-15 00:00:00

  • The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.

    abstract::Patients with lung cancer often present with metastatic disease and therefore have a very poor prognosis. The recent discovery of several novel ROS receptor tyrosine kinase molecular alterations in non-small cell lung cancer (NSCLC) presents a therapeutic opportunity for the development of new targeted treatment strat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3990

    authors: Jun HJ,Johnson H,Bronson RT,de Feraudy S,White F,Charest A

    更新日期:2012-08-01 00:00:00

  • Induction of neoplastic progression in Syrian hamster embryo cells treated with protein phosphatase inhibitors.

    abstract::In these studies, Syrian hamster embryo cells (SHE), which were isolated at different stages of neoplastic progression, were used to test the ability of the protein phosphatase inhibitors, okadaic acid and sodium orthovanadate (Na3VO4) to induce neoplastic progression. We observed that these chemicals can induce trans...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Afshari CA,Kodama S,Bivins HM,Willard TB,Fujiki H,Barrett JC

    更新日期:1993-04-15 00:00:00

  • Quantification of bleomycin pulmonary toxicity in mice by changes in lung hydroxyproline content and morphometric histopathology.

    abstract::Bleomycin treatment produced dose-dependent changes in lung collagen content and in several measurable histopathological parameters. NIH/Swiss mice were treated twice weekly for 6 weeks with bleomycin, 0, 1, 20, or 40 mg/kg s.c. The two highest doses produced mortalities of 35 and 100%, respectively, as well as loss o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sikic BI,Young DM,Mimnaugh EG,Gram TE

    更新日期:1978-03-01 00:00:00

  • An unexpected biotransformation pathway for tetrachloro-(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in the L1210 cell line.

    abstract::Tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) has been considered a prodrug which would be converted rapidly to dichloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(II) [PtCl2(dach)] under physiological conditions. However, the biotransformations of tetraplatin have not been studied in detail. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chaney SG,Gibbons GR,Wyrick SD,Podhasky P

    更新日期:1991-02-01 00:00:00

  • Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis.

    abstract::Angiopoietin-1 (Ang1) mediates angiogenesis by enhancing endothelial cell survival and migration. It is also known that Ang1 activates Tie2, an endothelial-specific tyrosine kinase receptor, but the molecular mechanism of this process is not clear. In this study, we investigated whether reactive oxygen species (ROS) p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3640

    authors: Kim YM,Kim KE,Koh GY,Ho YS,Lee KJ

    更新日期:2006-06-15 00:00:00

  • Bcl-2 overexpression enhances tumor-specific T-cell survival.

    abstract::Although immunotherapy based on the adoptive transfer of tumor-specific T lymphocytes has been shown to result in dramatic clinical responses in some patients, the relatively low levels of engraftment and persistence of the adoptively transferred cells may limit these responses in many patients. In an attempt to devel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2006

    authors: Charo J,Finkelstein SE,Grewal N,Restifo NP,Robbins PF,Rosenberg SA

    更新日期:2005-03-01 00:00:00

  • Depletion of adenosine diphosphate-ribosyl transferase activity in rat liver during exposure to N-2-acetylaminofluorene: effect of thiols.

    abstract::The exposure of rats to a feeding regimen containing N-2-acetylaminofluorene (2AAF) causes an accumulation of lesions on liver DNA and a progressive impairment in DNA repair capacity. We used the in vivo experimental model of Teebor and Becker (Cancer Res., 31:1-3, 1971) with the carcinogen given to rats during four c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cesarone CF,Scovassi AI,Scarabelli L,Izzo R,Orunesu M,Bertazzoni U

    更新日期:1988-07-01 00:00:00

  • Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter.

    abstract::The olfactory marker protein (OMP) is a M(r) 19,000 polypeptide originally considered a selective marker for differentiated olfactory receptor neurons. In an attempt to induce neoplastic proliferation in the olfactory cells, we made mice transgenic for the simian virus 40 large T-antigen gene linked to the OMP gene pr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Servenius B,Vernachio J,Price J,Andersson LC,Peterson PA

    更新日期:1994-10-01 00:00:00

  • ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier.

    abstract::Delivery of therapeutic agents to the brain and its neoplasms depends on the presence of membrane transport proteins in the blood-brain barrier and in the target cells. The cellular and subcellular localization of these membrane transporters determines the drug accessibility to the brain and its tumors. We therefore a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1271

    authors: Bronger H,König J,Kopplow K,Steiner HH,Ahmadi R,Herold-Mende C,Keppler D,Nies AT

    更新日期:2005-12-15 00:00:00

  • Differential effects of dietary linoleic acid on mouse skin-tumor promotion and mammary carcinogenesis.

    abstract::On the basis of reports of rat mammary- and pancreas-tumor models, we hypothesized that an increase in consumption of linoleic acid (LA) would also cause an enhancement in mouse skin-tumor promotion. SEN-CAR mice were placed on diets containing 0.8%, 2.2%, 3.5%, 4.5%, 5.6%, 7.0%, or 8.4% LA, 1 week after initiation wi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fischer SM,Leyton J,Lee ML,Locniskar M,Belury MA,Maldve RE,Slaga TJ,Bechtel DH

    更新日期:1992-04-01 00:00:00

  • Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.

    abstract::Using a microcytotoxicity assay we have studied the immune responses to the preneoplastic, hyperplastic alveolar nodule (HAN) lines D1 and D2 and to the mammary tumors arising spontaneously from them in BALB/c mice. Lymph node cells (LNC) from mice bearing HAN implants, or from mice whose implants had been removed gre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Heppner GH,Kopp JS,Medina D

    更新日期:1976-02-01 00:00:00

  • Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.

    abstract::Noncytotoxic spleen cells from BALB/c mice bearing 15- to 26-mm (but not 29-mm) s.c. MOPC-315 tumors that were cultured in medium containing 2% polyethylene glycol 6000 (PEG) developed substantial levels of anti-MOPC-315 cytotoxicity as assayed by 51Cr release. The level of cytotoxicity obtained increased with progres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Przepiorka D,Mokyr MB,Dray S

    更新日期:1980-12-01 00:00:00

  • herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?

    abstract::The human ether-a-go-go-related gene (herg) encodes a K+ current (IHERG) that plays a fundamental role in heart excitability by regulating the action potential repolarization (IKr); mutations of this gene are responsible for the chromosome 7-linked long QT syndrome (LQT2). In this report, we show that in a variety (n ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bianchi L,Wible B,Arcangeli A,Taglialatela M,Morra F,Castaldo P,Crociani O,Rosati B,Faravelli L,Olivotto M,Wanke E

    更新日期:1998-02-15 00:00:00

  • Induction of release of cytotoxin from murine bone marrow cells by an animal lectin.

    abstract::An animal lectin purified from loach (Misgurnus anguillicaudatus) eggs induced release of cytotoxin from fresh bone marrow cells from mice, although the other lectins tested, wheat germ agglutinin, concanavalin A, and phytohemagglutinin did not. The cytotoxin released from bone marrow cells was a heat-labile protein w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Okutomi T,Nakajima Y,Sakakibara F,Kawauchi H,Yamazaki M

    更新日期:1987-01-01 00:00:00

  • Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation.

    abstract::Although dendritic cell (DC) function is impaired in pancreatic cancer patients, the underlying mechanisms are unknown. This study analyzed the soluble factors released by pancreatic cancer cells responsible for inhibiting DC differentiation and activation. Medium conditioned by a highly metastatic human pancreatic ca...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3963

    authors: Bharadwaj U,Li M,Zhang R,Chen C,Yao Q

    更新日期:2007-06-01 00:00:00

  • Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.

    abstract::The alkylating agent temozolomide, commonly used in the treatment of malignant glioma, causes cellular cytotoxicity by forming O(6)-methylguanine adducts. In this report, we investigated whether temozolomide alters the activity of the transcription factor nuclear factor-kappaB (NF-kappaB). Temozolomide inhibits basal ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4496

    authors: Yamini B,Yu X,Dolan ME,Wu MH,Darga TE,Kufe DW,Weichselbaum RR

    更新日期:2007-07-15 00:00:00

  • Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability.

    abstract::Phosphorylation of histone H3 at Ser-10 is required for maintenance of properchromosome dynamics during mitosis. AIM-1, a mammalian Ipl1/aurora kinase involved in H3 phosphorylation, is transcriptionally overexpressed in many tumor cell lines. Increased expression of the AIM-1 gene has been observed in human colorecta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ota T,Suto S,Katayama H,Han ZB,Suzuki F,Maeda M,Tanino M,Terada Y,Tatsuka M

    更新日期:2002-09-15 00:00:00

  • Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.

    abstract::In a separate study (F. Courjal et al., Cancer Res., 57: 4360-4367, 1997), we have analyzed by Southern blotting the relationship between DNA amplification and clinicopathological features of breast cancer. Six regions of recurrent amplifications were tested (8p12, 8q24, 11q13, 12q13, 17q12, and 20q13), and the result...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Courjal F,Theillet C

    更新日期:1997-10-01 00:00:00

  • Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.

    abstract::The histone demethylase KDM4B is frequently overexpressed in various cancer types, and previous studies have indicated that the primary oncogenic function of KDM4B is its ability to demethylate H3K9me3 in different tumors, resulting in altered gene expression and genome instability. A genome-wide analysis to evaluate ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1310

    authors: Xiang Y,Yan K,Zheng Q,Ke H,Cheng J,Xiong W,Shi X,Wei L,Zhao M,Yang F,Wang P,Lu X,Fu L,Lu X,Li F

    更新日期:2019-01-01 00:00:00

  • Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.

    abstract::Monoclonal antibodies (McAbs) to human bladder carcinoma were generated by fusion of NS-1 mouse myeloma cells with spleen cells from BALB/c mice immunized with either cultured human bladder cancer cells or cells obtained from a fresh surgically removed bladder tumor. Four hybridomas which reacted strongly with bladder...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Young DA,Prout GR Jr,Lin CW

    更新日期:1985-09-01 00:00:00

  • T lymphocytes restrain spontaneous metastases in permanent dormancy.

    abstract::Tumor dormancy is a clinical phenomenon related to immune equilibrium during cancer immunoediting. The mechanisms involved in dormant metastases are poorly understood due to the lack of preclinical models. Here, we present a nontransgenic mouse model in which spontaneous metastases remain in permanent immunomediated d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-2084

    authors: Romero I,Garrido C,Algarra I,Collado A,Garrido F,Garcia-Lora AM

    更新日期:2014-04-01 00:00:00

  • Effects of tumor promoters on the expression of a tumor-related multigenic set in human cells.

    abstract::We previously found that a minor subfraction of the human genomic DNA, corresponding to 2500-3000 nonrepetitive sequences of 3 kilobases each and designated as tumor-activated DNA (TaDNA) was transcriptionally active in Burkitt's lymphoma cells and almost inactive in normal lymphocytes growing in vitro following integ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hanania N,Castagna M,Shaool D,Zeliszewski D,Harel J

    更新日期:1985-12-01 00:00:00

  • ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors.

    abstract::The endoplasmic reticulum aminopeptidase ERAP1 regulates innate and adaptive immune responses by trimming peptides for presentation by MHC class I (MHC-I) molecules. Herein, we demonstrate that genetic or pharmacological inhibition of ERAP1 on human tumor cell lines perturbs their ability to engage several classes of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1643

    authors: Cifaldi L,Romania P,Falco M,Lorenzi S,Meazza R,Petrini S,Andreani M,Pende D,Locatelli F,Fruci D

    更新日期:2015-03-01 00:00:00

  • A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction.

    abstract::A quantitative assessment of rate-limiting steps in metastasis has always been challenging because of the difficulty of detecting small tumor cell populations. We have developed a highly sensitive assay for monitoring the metastatic dissemination of human tumor cells in the chick embryo and used this assay to investig...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zijlstra A,Mellor R,Panzarella G,Aimes RT,Hooper JD,Marchenko ND,Quigley JP

    更新日期:2002-12-01 00:00:00

  • Involvement of disulfide bond formation in the activation of heparanase.

    abstract::Heparanase is overexpressed in many solid tumor cells and is capable of specifically cleaving heparan sulfate, and this activity is associated with the metastatic potential of tumor cells; however, the activation mechanism of heparanase has remained unknown. In this study, we investigated the link between disulfide bo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1053

    authors: Simizu S,Suzuki T,Muroi M,Lai NS,Takagi S,Dohmae N,Osada H

    更新日期:2007-08-15 00:00:00

  • cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E.

    abstract::Data are presented indicating marked antineoplastic activity for cis-dichlorodiammineplatinum(II) in MOPC 104E myeloma. One-eighteenth of the dose that produced 100% cures can be combined with noncurative, low doses of cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea to produce antineoplastic activity of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ghanta VK,Jones MT,Woodard DA,Durant JR,Hiramoto RN

    更新日期:1977-03-01 00:00:00